Other languages Biofrontera Deutsche Boerse AG

Equities

Delayed Deutsche Boerse AG Other stock markets 11:48:04 13/05/2024 am IST			5-day change	1st Jan Change
0.298 ^EUR	-12.87%		-.--%	-.--%

31/05	Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
15/05	Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M	MT

Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024	31/05
Biofrontera : Quartalsmitteilung zum 1. Quartal Q1/2024	31/05
Biofrontera : GESCHÄFTSORDNUNG FÜR DEN AUFSICHTSRAT	27/05
Biofrontera : Leonteq Securities AG - Aufhebung der Zulassung zum Handel (Sponsored Segment)	14/05
Biofrontera : Bezugsangebot	08/05
Biofrontera : Announcement of capital reduction (German only)	08/05
Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
Biofrontera : Jahresfinanzbericht 2023 nach HGB	30/04
Biofrontera : Abstimmungsergebnisse	04/04
Biofrontera Files Prospectus for Potential Secondary Stock Offerings	11/03
MORNING BRIEFING - Deutschland/Europa -2-	16/02
Biofrontera AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11
Biofrontera Licensor Gets FDA Approval for New Formulation of Ameluz to Treat Actinic Keratosis	10/23/10
Biofrontera AG Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31
Biofrontera Says Skin Disease Therapy Was Well-Tolerated in Phase 1 Safety Trial	28/23/28
Biofrontera Completes Patient Enrollment in Skin Cancer Treatment Study	10/23/10
Top Premarket Decliners	21/23/21
Biofrontera Launches Novel Belixos Active Care	05/23/05
Biofrontera to Effect 1-for-20 Reverse Stock Split	03/23/03
Wall Street Set to Open Lower; Housing Starts Rise More Than Expected	20/23/20

No results for this search